MedPath

A examination test of effects on blood pressure by consumption of the test food

Not Applicable
Conditions
Healthy adults
Registration Number
JPRN-UMIN000035223
Lead Sponsor
CPCC Company Limited
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
72
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Subjects who have a disease or who are given continuous treatment by taking medicines. (2) Subjects who plan to start treatment by taking medicines such as pollen allergy during the test term. (3) Subjects who constantly use oral medicines, functional foods, health foods and/or supplements having a possibility of affecting blood pressure. (4) Smokers (5) Females who are pregnant or lactating, and females who could become pregnant or lactating during test period. (6) Subjects who have previous and/or current medical history of serious disease (e.g., heart, liver, kidney, digestive organ). (7) Subjects who excessive alcohol intake. (8) Subjects who have extremely irregular dining habits, and subjects who have irregular life rhythm such as shift work or midnight work. (9) Subjects who have previous medical history of allergy for drugs, foods (especially for melon and apple), ribgrass pollen and/or lawn pollen. (10) Subjects who are weak to acidic taste (11) Subjects who are participating the other clinical tests. Subjects who participated within 4-weeks prior to the current study and/or who plan to participate the other clinical tests. (12) Subjects who donated over 200mL blood and/or blood components within the last one month to the current study. (13) Males who donated over 400mL blood within the last three months to the current study. (14) Females who donated over 400mL blood within the last four months to the current study. (15) Males who will be collected over 1200mL blood, when the sampling amounts within the last twelve months are adding to the planned sampling amounts of this study. (16) Females who will be collected over 800mL blood, when the sampling amounts within the last twelve months are adding to the planned sampling amounts of this study. (17) Others who have been determined ineligible by principal investigator or sub-investigator.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
*Blood pressure
Secondary Outcome Measures
NameTimeMethod
*Changing rate of blood pressure *Emission volume of sodium ion in 24-hours urine *Incidence of adverse events and of side effects
© Copyright 2025. All Rights Reserved by MedPath